↓ Skip to main content

Dietary Consumption of Black Raspberries or Their Anthocyanin Constituents Alters Innate Immune Cell Trafficking in Esophageal Cancer

Overview of attention for article published in Cancer Immunology Research, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dietary Consumption of Black Raspberries or Their Anthocyanin Constituents Alters Innate Immune Cell Trafficking in Esophageal Cancer
Published in
Cancer Immunology Research, January 2016
DOI 10.1158/2326-6066.cir-15-0091
Pubmed ID
Authors

Daniel S Peiffer, Li-Shu Wang, Noah P Zimmerman, Benjamin W S Ransom, Steven G Carmella, Chieh-Ti Kuo, Jo-Hsin Chen, Kiyoko Oshima, Yi-Wen Huang, Stephen S Hecht, Gary D Stoner

Abstract

Freeze-dried black raspberries (BRB), their component anthocyanins (ACs), and a metabolite of BRB ACs, protocatechuic acid (PCA), inhibit the development of esophagus cancer in rats induced by the carcinogen, N-nitrosomethylbenzylamine (NMBA). All three components reduce inflammation in the esophagus and in plasma. The present study determined the relation of changes in inflammatory markers to infiltration of innate immune cells into NMBA-treated esophagus. Rats were injected with NMBA (0.35 mg/kg) for five weeks while on control diet. Following NMBA treatment, rats were fed diets containing 6.1% BRB powder, an AC-rich fraction of BRBs (3.8 µmoles/g diet), or 500 ppm PCA. At weeks 15, 25 and 35, inflammatory biomarker expression in the plasma and esophagus was quantified and infiltration of immune cells in the esophagus was examined. At all three time points, BRB, AC, and PCA similarly affected cytokine production in the esophagus and plasma of NMBA-treated rats, relative to the NMBA-only control. These included decreased expression of the pro-inflammatory cytokine IL1β, and increased the expression of the anti-inflammatory cytokine IL10. Moreover, all three diets also increased the expression of IL12, a cytokine that activates both cytolytic NK and CD8+ T cells. Additionally, the three diets also decreased infiltration of both macrophages and neutrophils into the esophagus. Overall, our results suggest that another mechanism by which BRBs, ACs, and PCA inhibit NMBA-induced esophageal tumorigenesis is by altering cytokine expression and innate immune cell-trafficking into tumor tissues.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 15%
Other 4 10%
Student > Postgraduate 4 10%
Student > Ph. D. Student 4 10%
Researcher 3 7%
Other 8 20%
Unknown 12 29%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 17%
Medicine and Dentistry 6 15%
Biochemistry, Genetics and Molecular Biology 4 10%
Nursing and Health Professions 2 5%
Chemical Engineering 1 2%
Other 6 15%
Unknown 15 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2022.
All research outputs
#2,607,366
of 22,834,308 outputs
Outputs from Cancer Immunology Research
#279
of 1,405 outputs
Outputs of similar age
#46,672
of 393,071 outputs
Outputs of similar age from Cancer Immunology Research
#9
of 51 outputs
Altmetric has tracked 22,834,308 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,071 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.